Naphthalene exposure: Effects on gene expression and proliferation in human cord blood cells

Journal of Biochemical and Molecular Toxicology

Volumn 17, Issue 5, 2003, Pages 286-294

  Diodovich, Cristina ^a,b   Malerba, Ilaria ^a,b   Bowe, Gerard ^a   Acquati, Francesco ^c   Bianchi, Marco Giorgio ^c   Taramelli, Roberto ^c   Parent Massin, Dominique ^b   Gribaldo, Laura ^a  

^a ECVAM   (Italy)

^b UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Apoptosis; Gene expression; Human cord blood cells; Macroarray; Naphthalene

Indexed keywords

INTERLEUKIN 8; NAPHTHALENE; PROTEIN BCL 2; PROTEIN C FOS; PROTEIN C JUN; PROTEIN PRECURSOR; RAF PROTEIN; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BLOOD TOXICITY; CARCINOGENICITY; CELL ACTIVITY; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME MECHANISM; EXPOSURE; GENE EXPRESSION PROFILING; GENE INDUCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TOXICITY TESTING; UMBILICAL CORD BLOOD; WESTERN BLOTTING;

APOPTOSIS; CELL CYCLE PROTEINS; CELL DIVISION; CELLS, CULTURED; FETAL BLOOD; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; NAPHTHALENES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 0242268552     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.10091     Document Type: Article

References (27)

1. Risk assessment document for naphthalene (EC), November 2000 to March 2001.
2. Bieniek G, Cisowska G, Lusiak T, Siwek A. Evaluation of exposure to benzene and naphthalene in coke plant workers. Med Pr 1993;44(6):579-586.
3. Toxicology and carcinogenesis studies of naphthalene (CAS no. 91-20-3) in F344/N rats (inhalation studies). Natl Toxicol Program Tech Rep Ser 2000;500:1-173.
4. Sorahan T, Hamilton L, Jackson JR. A further cohort study of workers employed at a factory manufacturing chemicals for the rubber industry, with special reference to the chemicals 2-mercaptobenzothiazole (MBT), anilane, phenyl-beta-naphthylamine and o-toluidine. Occup Environ Med 2000;57(2):106-115.
5. Todisco V, Lamour J, Finberg L. Haemolysis from exposure to naphthalene mothballs. N Engl J Med 1991;325(23):1660-1661.
6. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993;81:2844-2853.
7. Vial T, Nicolas B, Descotes J. Clinical immunotoxicity of pesticides. J Toxicol Environ Health 1996;48:215-219.
8. Verhaegh GW, Richard MJ, Hainaut P. Mol Cell Biol 1997;17:5699-5706.
9. Gibson L, Holmgreen SP, Huang DC, Bernard O, Copeland NG, Jenkins NA, Sutherland GR, Baker E, Adams JM, Cory S. Bcl-w, a novel member of the BCL-2 family, promotes cell survival. Oncogene1996;13(4):665-675.
10. Yang J, Liu X, Bhaila K, Kim CN, Ibrado, AM, Cai J, Peng TI, Jones DP, Wang X. Prevention of apoptosis by BCL-2: Release of cytocrome c from mitochondria blocked. Science 1997;275:1129-1136.
11. Rosse T, Olivier R, Monney L, Rager M, Conus S, Fellay I, et al. BCL-2 prolongs cell survival after BAX-induced release of cytocrome c. Nature 1998;391:496-499.
12. IARC Monographs 2002;82:367.
13. Chiarugi V, Ruggiero M. Role of three cancer "master genes" p53, BCL-2 and c-myc on the apoptotic process. Tumori 1996;82:205-209.
14. Blagosklonny MV, Darzynkiewicz Z. Cyclotherapy: Protection of normal cells an unshielding of cancer cells. Cell Cycle 2002;1:375-382.
15. Wang HG, Miyashita T, Takayama S, Sato T, Tori T, Krajewski S, Tanaka S, Hovey L, Troppmai J, Rapp UR, et al. Apoptosis regulation by interaction of BCL-2 protein and RAF-1 kinase. Oncogene 1994;9:2751-2756.
16. Prasad DDK, Ouchida M, Lee L, Rao VN, Reddy ESP. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 1994;9(12):3717-3729.
17. Hicks GG, Singh N, Nashabi A, Mai S, Bozek G, Klewes L, Arapovic D, White EK, Koury MJ, Oltz EM, Van Kaer L, Ruley, HE. Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet 2000;24(2):175-179.
18. Panagopoulos I, Aman P, Mandahl N, Mitelman F. Two distinct FUS breakpoint clusters in myxoid liposarcoma and acute myeloid leukemia with the translocations t(12;16) and t(16;21). Oncogene 1995;11:1133-1137.
19. Zinszner H, Sok J, Immanuel D, Yin Y, Ron D. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci 1997;110:1741-1750.
20. Perrotti D, Bonatti S, Trotta R, Martinez R, Skorski T, Salomoni P, Grassilli E, Lozzo RV, Cooper DR, Calabretta B. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. EMBO J 1998;17(15):4442-4455.
21. Bertrand P, Akhmedov AT, Delacote F, Durrbach A, Lopez BS. Human POMp75 is identified as the pro-oncoprotein TLS/FUS: Both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation. Oncogene 1999;18(31):4515-4521.
22. Perrotti D, Iervolino A, Cesi V, Cirinná M, Lombardini S, Grassilli E, Bonatti S, Claudio PP, Calabretta B. BCR-ABL prevents c-JUN Mediated and Proteasome-Dependent FUS (TLS), Proteolysis through a Protein Kinase CβII-Dependent Pathway. Molecular and Cellular Biology 2000;20:6159-6169.
23. Leiden JM. Transcriptional regulation of T-cell receptor genes. Annu Rev Immunol 1993;11:539-570.
24. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;285:1798-1801.
25. Peichl P, Ceska M, Broell H, Effenberger F, Lindley IJ. Human neutrophil activating peptide/interleukin-8 acts as an autoantigen in rheumatoid arthritis. Ann Rheum Dis 1992;51:19-22.
26. Tilg H, Ceska M, Vogel W, Herold M, Margreiter R, Huber C. Interleukin-8 serum concentrations after liver transplantation. Transplantation 1992;53:800-803.
27. Shyamala V, Khoja H, Moghadam M. Inhibition of adenylyl cyclase by alpha chemokines IL-8 and GRO-alpha in Chinese hamster ovary cells expressing R1 and R2 receptors. J Interferon Cytokine Res 1998;18(4):235-239.